Researchers have developed a novel nanoparticle-based drug delivery system that combines the anti-cancer drug vincristine with fluorescent carbon dots. This innovative approach could significantly improve the treatment of hepatocellular carcinoma, one of the most deadly forms of liver cancer. The nanoparticles not only deliver the drug more effectively to cancer cells, but also provide a way to monitor and track the treatment using the carbon dots’ fluorescent properties. This groundbreaking research opens up new possibilities for targeted cancer therapy and real-time imaging, which could lead to better outcomes for patients with this devastating disease.
Tackling the Challenges of Liver Cancer Treatment
Hepatocellular carcinoma (HCC) is a type of P-glycoprotein.
Combining Therapy and Imaging
The researchers developed a unique nanoparticle system that encapsulates the chemotherapy drug vincristine and fluorescent Click Here
